Galunisertib: Phase II data

An open-label, international Phase II trial in 40 advanced HCC patients with low serum alpha fetoprotein

Read the full 163 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE